Janux Therapeutics JANX Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $10M-5.6% | $10.59M+31.0% | $8.08M-6.1% | $8.61M+137% | ||
| $125.9M+84.1% | $68.39M+24.5% | $54.92M+2.8% | $53.44M+104% | ||
| $41.77M+1.8% | $41.05M+57.0% | $26.14M+17.4% | $22.26M+116% | ||
| $167.67M+53.2% | $109.44M+35.0% | $81.06M+7.1% | $75.7M+107% | ||
| -$157.67M-59.5% | -$98.85M-35.4% | -$72.98M-8.8% | -$67.09M-104% | ||
| -1,576.7%-643pp | -933.6%-30.7pp | -902.9%-124pp | -779%+126pp | ||
| $44.04M+47.5% | $29.85M+103% | $14.69M+264% | $4.03M+1,469% | ||
| $44.04M+47.5% | $29.85M+103% | $14.69M+264% | $4.03M+1,469% | ||
| -$113.63M-64.7% | -$68.99M-18.4% | -$58.29M+7.6% | -$63.06M-93.0% | ||
| -1,136.3%-485pp | -651.6%+69.6pp | -721.2%+11.0pp | -732.2%+166pp | ||
| -$1.83-44.1% | -$1.27+4.5% | -$1.33+12.5% | -$1.52+52.9% | ||
| -$1.83-44.1% | -$1.27+4.5% | -$1.33+12.5% | -$1.52-9.4% | ||
| 247.7M+16.9% | 211.9M+22.2% | 173.3M+4.6% | 165.8M+119% | ||
| 247.7M+16.9% | 211.9M+22.2% | 173.3M+4.6% | 165.8M— | ||
| $44.04M+47.5% | $29.85M+103% | $14.69M+264% | $4.03M+1,469% | ||
| -$157.67M-59.5% | -$98.85M-35.4% | -$72.98M-8.8% | -$67.09M-104% | ||
| -$155.64M-60.8% | -$96.79M-36.3% | -$71.02M-7.2% | -$66.25M-102% | ||
| -$155.64M-60.8% | -$96.79M-36.3% | -$71.02M-7.2% | -$66.25M-102% | ||
| -1,556.4%-642pp | -914.1%-35.4pp | -878.7%-109pp | -769.3%+133pp | ||
| -$157.67M-59.5% | -$98.85M-35.4% | -$72.98M-8.8% | -$67.09M-104% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Janux Therapeutics's revenue?
- Janux Therapeutics (JANX) generated $13.7M in revenue over the trailing twelve months, up 47.1% year over year.
- Is Janux Therapeutics profitable?
- Janux Therapeutics is not currently profitable: it reported a net loss of $114.5M over the trailing twelve months, a -833.6% net margin.
- What is Janux Therapeutics's earnings per share?
- Janux Therapeutics's diluted EPS over the trailing twelve months is $-1.84.
- Where does Janux Therapeutics's income statement data come from?
- Every line is extracted from Janux Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
